On January 16th, 2019, an all-star cast of musicians will honor the memory of the late Chris Cornell with a special tribute performance at The Forum in Los Angeles, CA.Billed as “I Am The Highway: A Tribute To Chris Cornell,” the tribute show will feature members of Cornell’s three most notable bands—Soundgarden, Audioslave, and Temple of the Dog—several of whom are now best known as members of other groups like Pearl Jam and Rage Against The Machine.In addition, the special tribute show will feature Foo Fighters, Metallica, and Ryan Adams. According to the announcement art, “I Am The Highway: A Tribute To Chris Cornell” will be hosted by late-night TV host and comedian Jimmy Kimmel as well as other surprise guests. Proceeds from the show will benefit the Epidermolysis Bullosa Medical Research Foundation (EBMRF).Watch Chris Cornell And Eddie Vedder’s Final “Hunger Strike” Duet From Bridge School Benefit ’14Though the announcement comes almost a year and a half after Cornell’s shocking suicide, the music world still feels the pains of his untimely death. In addition to countless live tributes by a bevy of artists, the Museum of Pop Culture in Chris Cornell’s native Seattle, WA recently unveiled a life-sized bronze statue of the grunge hero. Cornell’s estate also recently announced a new posthumous LP and retrospective box set simply titled Chris Cornell, which will be released on November 16th—the same day tickets to “I Am The Highway” go on sale.Tickets for “I Am The Highway: A Tribute To Chris Cornell” at The Forum go on sale to the general public this Friday, November 16th at 10 a.m. PST. For more information, or to grab your tickets when they go on sale, head here.
A top European Union (EU) official rejected a return to protectionist trade policies to shelter struggling European companies during tough economic times, calling instead for increased economic cooperation with the United States and a more open global economy.“We cannot bring back from the grave the policy of picking winners that European countries embraced,” Joaquín Almunia, European Commission vice president and commissioner for competition, said Thursday during a Harvard talk. “I have to reject these calls for relaxed enforcement of competition policies. This does not mean Europe does not need an industrial policy. The question is what kind of industrial policy. We embrace a modern industrial policy and reject the old-style policy from the 1970s.”Almunia was at the Minda de Gunzburg Center for European Studies as part of the center’s Director’s Seminar series. He was introduced by Grzegorz Ekiert, the center’s director and a professor of government.Almunia, who completed the Senior Managers in Government program at Harvard Kennedy School in 1991, called for increased economic cooperation with the United States through the Transatlantic Trade and Investment Partnership, which would reduce tariffs, smooth regulatory hurdles, and coordinate standards and certifications to ease trade between the U.S. and the EU. The first negotiation occurred in July in Washington, D.C.; a second round is planned for October in Brussels.During a question-and-answer session after Almunia’s speech, Ekiert said that many observers are pessimistic that such an agreement can be reached. The EU has a record of overcoming difficult hurdles, Almunia answered, from its very inception to its handling of the recent sovereign debt crisis, which required the creation of institutions before any action could be taken to quell the crisis.“The day after Lehman Brothers went bust, Europe was not prepared to deal with the crisis. We didn’t have the tools,” Almunia said. He added that, “I am optimistic” about the trade negotiations.The European Commission is the European Union’s executive body, headed by President José Manuel Barroso and responsible for the EU’s day-to-day operations. It has one member from each of the EU’s 28 countries. Almunia has been on the commission since 2004.If the U.S. and the EU can come to a new trade agreement, Almunia said, it would signal to the rest of the world that economic cooperation and open economies are the way to go, fostering increasingly open trade around the globe that would help Western businesses.Within the EU, it’s important to create as level a playing field as possible, so that European companies can compete with one another, he said. Two ways the EU seeks to do that is through antitrust actions against cartels and by reviewing public subsidies to specific industries.
Features New 2020 tunes on the horizon; Sturgill Simpson plays Southern arenas Readers pick their favorite race, faces, and places in the region. A major climate report offers a bleak forecast for the ski industry. Local Favorites: Gear made in the Blue Ridge The Slopes on a Budget TRAIL MIX Boat Rock bouldering competition – R.I.P. Jake Burton Carpenter – Scenes from North Carolina’s Shut-In Ridge Trail Race – Gear made in the Blue Ridge – Frigid running in Pennsylvania – Brewery makes edible packaging THE GOODS On the Cover Thirty-three years after publishing Southern Snow: The Winter Guide to Dixie, author Randy Johnson reflects on the cult classic, which has just been reissued with a second edition. Quick Hits LWCF: Four letters that every outdoor adventurer should know 2020 RACE AND EVENT GUIDE Best of the Blue Ridge Photo by Justin Potter, WINNER of the BLUE RIDGE OUTDOORS COVER PHOTO CONTEST. Determined to get his kids on the mountain, an avid skier shares tips for making resort runs affordable. “Unviable” Snow in the South Perspective Departments Justin set out to capture the Rhododendrons blooming but was treated to one of the most beautiful sunrises of the year!
Spain said on October 14, it will request the extradition from Cuba of an alleged member of the Basque separatist group ETA who allegedly sought explosives training from Colombian rebel group the Revolutionary Armed Forces of Colombia (FARC). Venezuelan authorities detained Jose Ignacio Echarte and two other suspected ETA members in August after the boat they were in ran aground on the Venezuelan island of Los Roques, just south of Cuba. They then turned him over to Cuban authorities. The extradition request is based on information found on computer archives seized from three ETA leaders in Paris in 1999, which allegedly showed Echarte had requested permission to work with explosives, Spain’s Justice Ministry said in a statement. “Echarte requested permission to take part, with several members of FARC, in the launch of grenades and mortars in the Colombian-Venezuelan jungle,” it said. Spain’s National Court Judge Eloy Velasco, who has been investigating suspected ties between ETA and FARC, had issued an international arrest warrant for Echarte and requested his extradiction from Cuba. The government approved Justice Minister Francisco Caamaño’s decision to file the extradition request for Echarte at a cabinet meeting on October 14, the Justice Ministry statement said. ETA is held responsible for 829 deaths in its battle to carve out an independent Basque homeland in northern Spain and southwestern France. FARC is the oldest and largest leftist guerilla group in Colombia with an estimated 8,000 combatants. By Dialogo October 18, 2011
With that in mind, we found so many face masks that are bound to be solid additions to your collection. While it may be uncomfortable at times, wearing a mask is a crucial action in order to help our communities stay safe during this trying time. Face masks may not fully protect you or others from contracting every type of viral infection, but wearing an appropriate covering can significantly reduce the rate of which illness can spread. Do your part and pick out one of the personality-filled masks below, or grab one as a stocking stuffer for the holiday season! Us Weekly has affiliate partnerships so we may receive compensation for some links to products and services.Please note: Information below is not intended to diagnose, treat, cure or prevent any disease or health condition.- Advertisement – See tips and information from the CDC.It’s no secret that face masks have become a daily accessory. When the COVID-19 pandemic began, we had a small selection to choose from. In fact, we were all clamoring for any type of face covering that we could get — while making sure medical-grade options were reserved for frontline workers who needed them most. Since then, the offering has evolved. Brands have developed reusable cloth masks that are seriously stylish, and can show off our personalities in the process. Honestly, some of them are actually quite funny — and can potentially put a (hidden) smile on someone’s face!Popular face masks today range from fun graphic prints, to political or personal statements, to funky designs. If we have to wear a mask — as we all should, per the current CDC guidelines — then why not at least try to have a little fun with the situation?- Advertisement – – Advertisement –
Jul 20, 2005 (CIDRAP News) – Indonesian officials confirmed today that a man and his two young daughters who died earlier this month had H5N1 avian influenza, though they had had no known contact with infected poultry.The 38-year-old man and his daughters, aged 1 and 9, were the first Indonesians to die of the illness. Indonesia has had a number of poultry outbreaks but only one previous human case, an asymptomatic one reported last month.Indonesian Health Minister Siti Fadillah Supari said laboratory tests in Hong Kong on samples from the man and one daughter confirmed that they had the virus, according to news services.Supari said it could be concluded that all three died of the illness. “We don’t distinguish between the three,” an Agence France-Presse (AFP) report quoted her as saying.Though there was no evidence that the three victims had been exposed to infected poultry, Supari said person-to-person transmission of the virus seemed unlikely, according to an Associated Press (AP) report. She said the virus strain that killed them had not mutated.”It’s the conventional H5N1 virus and not a new strain,” Bloomberg News quoted Supari as saying.Health agencies fear that the H5N1 virus will evolve so as to allow easy person-to-person transmission, leading to a pandemic. Only one probable instance of person-to-person transmission has been documented so far, that of an 11-year-old Thai girl who apparently passed the virus to her mother and an aunt last September. Person-to-person transmission was also suspected in some family case clusters in Vietnam this year.The Indonesian cases bring CIDRAP’s unofficial count of H5N1 deaths since late 2003 to 59, including 40 in Vietnam, 12 in Thailand, and 4 in Cambodia. Adding the three deaths to the World Health Organization’s current numbers yields a total of 111 cases with 57 deaths. The WHO has not yet recognized two fatal cases that the media reported recently in Vietnam.Dr. Georg Petersen, a WHO representative in Indonesia, said he was not too worried that the three victims had no known contact with sick birds, because the source of infection is often very hard to find, according to the AP.Petersen said that in view of Indonesia’s history of avian flu outbreaks, the deaths were not a big surprise, according to the AFP report. He added that the three victims “may have had contact with chicken droppings.”Bloomberg News said the three people lived in Tangerang, about 15 miles west of Jarkarta. The report said 1-year-old Thalita Nurul Azizah died Jul 9, followed by her father, Iwan Siswara Rifei, on Jul 12 and her 9-year-old sister, Sabrina Nurul Aisyah, on Jul 14.Supari and Petersen said none of the 315 people who may have had contact with the family have fallen ill, according to the Bloomberg report. The health ministry has taken samples from the contacts and is monitoring them.A veterinary official said all farms within 20 kilometers of the victims’ home were being tested for avian flu, and results were expected back next week, the AP reported.The only previous human case of H5N1 avian flu in Indonesia involved a poultry worker who was tested last March, though he had not been sick. He was found to have a low level of antibodies to the virus, according to results reported in June.Indonesia has had a number of H5N1 outbreaks in poultry, going as far back as August 2003. In May of this year, some pigs in the Tangerang district—the same district where Rifei and his daughters lived—were found to have H5N1 infections without signs of illness. The pigs lived near poultry farms that had been hit by the virus.See also:Indonesia’s report to the World Organization for Animal Health (OIE) on H5N1 infections in pigsftp://ftp.oie.int/AVIAN%20INFLUENZA/infos_san_archives/eng/2005/en_050527v18n21.pdf
“VaxInnate’s M2e universal flu vaccine candidate has passed a critical initial test,” David Taylor, MD, the company’s chief medical officer, said in the news release. “We’re encouraged by these data, which demonstrate that the vaccine is safe and elicits potent immune responses at doses below a microgram [mcg] of vaccine antigen, and does so without the use of conventional adjuvants.” The vaccine, made by VaxInnate Inc., Cranbury, N.J., targets the M2 protein of influenza A viruses, a surface protein that differs little among different strains of type A. Existing flu vaccines target hemagglutinin (HA), a flu surface protein that often mutates, making it necessary to change the vaccine each year to cover the predominant strains in circulation. A vaccine targeting a protein found in all or most flu strains could reduce or eliminate the need to change the vaccine each year. “Should M2e be shown to be protective for influenza A, it’s possible that other universal antigens could be developed for influenza B,” Taylor said in an e-mailed statement. “In the developing world, where influenza vaccine is not available, M2e could be a cost-effective way to provide influenza A coverage. He also commented that VaxInnate is developing seasonal flu vaccines in which its recombinant-bacteria technology is used to make both the A and B components. A vaccine targeting a Solomon Islands strain of H1N1 is currently in clinical testing, and a type B vaccine may become available next year, he said. The two lowest doses were safe and well-tolerated in all the volunteers; they yielded an immune response in 18 of 24 volunteers after the first dose and in 23 of 24 after two doses, VaxInnate said. However, the two highest doses “were associated with the presence of flu-like symptoms in some of the subjects.” Nov 11, 2008 (CIDRAP News) – A vaccine designed to offer protection against many strains of influenza viruses appeared safe in low doses and triggered a satisfactory immune response in a phase 1 clinical trial, the vaccine’s developer announced recently. Plans for targeting type BThe M2e vaccine targets influenza A but not influenza B, the other major type. Type A viruses generally cause more severe illness than type B. Seasonal flu vaccines normally target two type A subtypes—H1N1 and H3N2—and one type B strain, all of which typically circulate each season. “Given the strength of the antibody responses and the absence of significant adverse reactions at the two lowest doses (0.3 and 1.0 mcg), VaxInnate intends to continue development and clinical evaluation of the vaccine candidate at doses of 1.0 mcg and less,” the company said. Flagellin interacts with the immune system’s toll-like receptors, which serve in human immune cells as sentries to detect pathogens and mount a general defense, according to VaxInnate. This initial defense stimulates an adaptive immune response that includes production of pathogen-specific antibodies, the company said. In the trial, 60 healthy volunteers between the ages of 18 and 49 received one of the four doses or a placebo in two injections 28 days apart, the company reported. Safety was assessed 1 and 7 days after immunization, and immune response was examined 7, 14, and 28 days after each dose. Seroconversion was defined as a serum IgG and anti-M2e antibody value of at least 0.174 mcg per milliliter and a fourfold increase in antibody titer. Christine Turley, MD, primary investigator in the study, said in the release that the results for the two lowest doses “suggest that the M2e vaccine candidate could be a promising and much-needed new option for prevention or attenuation of influenza A disease.” She is director of clinical trials and clinical research in the Sealy Center for Vaccine Development, University of Texas Medical Branch (UTMB), Galveston. Fewest events at lowest dosesThe phase 1 trial was a double-blind study designed to test the safety and immunogenicity of four different doses of the vaccine: 0.3, 1, 3, and 10 mcg. It was conducted in Galveston, Tex., and Lenexa, Kan. See also: “The notion of a universal influenza vaccine or any kind of influenza vaccine that reduces the need for annual vaccination or provides better or more reliable protection against influenza viruses—that will be very useful to us,” she said. “Until a vaccine goes all the way through phase 3 clinical trials and we have good evidence about actual protection, the verdict is out. But certainly there are a number of kinds of vaccines in development, such as this one, that are exciting with regard to the prospect of a more universal kind of vaccine.” “VaxInnate is working to develop a second-generation universal vaccine that has M2e and another conserved antigen that will address influenza B strains, as well as influenza A strains. Efficacious universal vaccines for influenza that cover both A and B strains could potentially replace the more standard HA vaccine in some markets and market segments, even in the developed world.” While acknowledging that the M2e vaccine would not cover type B viruses, VaxInnate’s Taylor told CIDRAP News that the company also hopes to develop a second-generation universal vaccine that would target both A and B. Meanwhile, he suggested possible uses for the M2e vaccine by itself, assuming it is successful. Nichol said the measures of immune response used by VaxInnate are reasonable and generally correlate with actual protection, but do not guarantee it. “It’s encouraging but not definitive until we see the clinical protection data,” she said. ‘Encouraging but not definitive’Dr. Kristin Nichol, an experienced flu immunization researcher who was not involved with the study, described VaxInnate’s results as promising but advised a wait-and-see attitude. She is associate chief of staff for research at the Minneapolis VA Medical Center. Taylor also said that in countries where conventional seasonal flu vaccines are available, the M2e vaccine could be used in combination with them to provide increased protection in case the strains in the seasonal vaccine don’t match well with circulating strains. The vaccine consists of the ectodomain of the M2 protein, fused to flagellin, a bacterial protein. The company uses recombinant bacteria to produce the vaccine, a technique that the company says is faster than conventional egg-based production or cell-culture production. The Bill and Melinda Gates Foundation supported the M2e vaccine trial with a $9.5 million grant to UTMB to improve control of flu in the developing world, the company said. The company reported the results in an Oct 26 press release and at the Interscience Conference on Antimicrobial Agents and Chemotherapy/Infectious Diseases Society of America (ICAAC/IDSA) meeting, held Oct 24-28 in Washington, DC. Oct 26 VaxInnate press releasehttp://www.vaxinnate.com/pages/pressreleases/20081026_001.html
Would you like to read more?Register for free to finish this article.Sign up now for the following benefits:Four FREE articles of your choice per monthBreaking news, comment and analysis from industry experts as it happensChoose from our portfolio of email newsletters To access this article REGISTER NOWWould you like print copies, app and digital replica access too? SUBSCRIBE for as little as £5 per week.
Facebook Forgot Password ? LOG INDon’t have an account? Register here The House of Representatives’ proposal to bring back banking supervision to Bank Indonesia (BI) has drawn criticism as experts warn of possible moral hazard and regulatory uncertainty.In a draft revision of the 1999 and 2004 BI laws, the House’s Legislative Body (Baleg) proposed that the central bank take over the job of supervising banks from the Financial Services Authority (OJK). The gradual takeover process is expected to be completed by Dec. 31, 2023, at the latest.The OJK was established in 2011 to oversee the financial industry and it was modeled on the financial services regulatory structure that prevailed in the United Kingdom. It assumed the role of regulator and supervisor of banks in 2013, taking the responsibility from the central bank.The plan to return the role to the central bank will put the credibility of lawmakers and the government at stake, said U… Log in with your social account Google Linkedin Topics : OJK bank-indonesia Financial-Services-Authority BI-Law-revision banking-industry supervision